434 related articles for article (PubMed ID: 19103360)
1. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis.
Majoie IM; Oldhoff JM; van Weelden H; Laaper-Ertmann M; Bousema MT; Sigurdsson V; Knol EF; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Am Acad Dermatol; 2009 Jan; 60(1):77-84. PubMed ID: 19103360
[TBL] [Abstract][Full Text] [Related]
2. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial on photo(chemo)therapy of subacute prurigo.
Gambichler T; Hyun J; Sommer A; Stücker M; Altmeyer P; Kreuter A
Clin Exp Dermatol; 2006 May; 31(3):348-53. PubMed ID: 16681573
[TBL] [Abstract][Full Text] [Related]
6. Narrowband UVB phototherapy in skin conditions beyond psoriasis.
Gambichler T; Breuckmann F; Boms S; Altmeyer P; Kreuter A
J Am Acad Dermatol; 2005 Apr; 52(4):660-70. PubMed ID: 15793518
[TBL] [Abstract][Full Text] [Related]
7. The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy.
Clayton TH; Clark SM; Turner D; Goulden V
Clin Exp Dermatol; 2007 Jan; 32(1):28-33. PubMed ID: 17305905
[TBL] [Abstract][Full Text] [Related]
8. UVA/UVB phototherapy for atopic dermatitis revisited.
Valkova S; Velkova A
J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
[TBL] [Abstract][Full Text] [Related]
9. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis.
Tzaneva S; Seeber A; Schwaiger M; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2001 Oct; 45(4):503-7. PubMed ID: 11568738
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo.
El-Zawahry BM; Bassiouny DA; Sobhi RM; Abdel-Aziz E; Zaki NS; Habib DF; Shahin DM
Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):84-90. PubMed ID: 22409711
[TBL] [Abstract][Full Text] [Related]
12. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.
Tzaneva S; Kittler H; Holzer G; Reljic D; Weber M; Hönigsmann H; Tanew A
Br J Dermatol; 2010 Mar; 162(3):655-60. PubMed ID: 19769631
[TBL] [Abstract][Full Text] [Related]
13. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy.
Schnopp C; Rad R; Weidinger A; Weidinger S; Ring J; Eberlein B; Ollert M; Mempel M
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):81-5. PubMed ID: 17523929
[TBL] [Abstract][Full Text] [Related]
14. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
15. Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?
Pugashetti R; Lim HW; Koo J
J Dermatolog Treat; 2010 Nov; 21(6):326-30. PubMed ID: 19895327
[TBL] [Abstract][Full Text] [Related]
16. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
17. Management of atopic dermatitis using photo(chemo)therapy.
Gambichler T
Arch Dermatol Res; 2009 Mar; 301(3):197-203. PubMed ID: 19142651
[TBL] [Abstract][Full Text] [Related]
18. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study.
Borzova E; Rutherford A; Konstantinou GN; Leslie KS; Grattan CE
J Am Acad Dermatol; 2008 Nov; 59(5):752-7. PubMed ID: 18774200
[TBL] [Abstract][Full Text] [Related]
19. Phototherapy with UVB narrowband, UVA/UVBnb, and UVA1 differentially impacts serum 25-hydroxyvitamin-D3.
Feldmeyer L; Shojaati G; Spanaus KS; Navarini A; Theler B; Donghi D; Urosevic-Maiwald M; Glatz M; Imhof L; Barysch MJ; Dummer R; Roos M; French LE; Surber C; Hofbauer GF
J Am Acad Dermatol; 2013 Oct; 69(4):530-6. PubMed ID: 23850091
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
